HealthDay - MONDAY, Sept. 13 (HealthDay News) -- Although many men are concerned about prostate cancer, a new study finds that in men aged 55 to 74 with low levels of baseline prostate-specific antigen (PSA), further screening and early detection of prostate cancer offer virtually no benefit.
More...
More...